icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
RSc2eYYRfFQv7KGG
Listen
